Regression of Fibrosis and Cirrhosis in Chronic HCV Patients Treated with Interferon Based Therapy Comparison of the VERSANT HCV RNA qualitative assay (transcription-mediated amplification) and the COBAS AMPLICOR hepatitis C virus test, version 2.0, in patients undergoing interferon-ribavirin therapy Clinical Significance of Hepatic Iron Deposition and Serum Iron Values in Patients with Chronic Hepatitis C Infection . Predictors and non invasive identification of severe liver fibrosis in patients with chronic hepatitis C Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. A randomized controlled trial to assess the safety and efficacy of silymarin on symptoms, signs and biomarkers of acute hepatitis. Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Incidence and predictors of hematological side effects in chronic HCV Egyptian patients treated with PEGylated interferon and ribavirin A scoring model for prediction of relapse among chronic HCV genotype 4 patients treated with peginterferon and ribavirin. Reliability and validity of urine screening leukocyte esterase strips in diagnosis of spontaneous bacterial peritonitis. Elevation of pancreatic enzymes in patients with chronic liver diseases. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt) Histopathological characterization of genotype 4 chronic hepatitis C. Previous and silent hepatitis B infection in patients with chronic hepatitis C: Risk factors for severe hepatic fibrosis. Tumor necrosis alpha promoter gene polymorphisms and diabetes in patients with chronic hepatitis C: Evidence in favor of an association. Hepatitis C virus infection as a risk factor for development of type 2 diabetes mellitus: A prospective cross-sectional study. A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV Neurophysiologic and psychometric changes in patients with liver cirrhosis. Serum level of tumor necrosis factor-alpha in patients with hepatic encephalopathy due to chronic liver diseases. Prediction of relapse among chronic HCV genotype 4 patients treated with PEG-IFN and Ribavirine. Role of serum leptin in patients with liver cirrhosis and hepatocellular carcinoma complicating chronic viral hepatitis. Pulmonary functions after injection sclerotherapy of esophageal varices and after band ligation. CSF lactate: A rapid accurate diagnostic test for acute bacterial meningitis. Serum ferritin level as a predictor of response to pegylated interferon/ribavirin therapy in Egyptian chronic hepatitis C patients. High insulin resistance is associated with low rapid virological response in chronic HCV patients. A population based epidemiological study of Helicobacter Pylori in Egypt. Independent predictors of severe liver fibrosis in chronic hepatitis C. Significance of Hepatic Iron Deposition and Serum Iron Indices in Liver Fibrosis Associated with Chronic Hepatitis C. High body mass index is associated with advanced hepatic fibrosis in patients chronic hepatitis C. Journal of Hepatology 2002; 36, Suppl 1, 240. (Presented in the Eurobean Association of Study of Liver Diseases and Intenational Association of Study of Liver Disease annual meeting, 2001, Madrid, Spain). Primary author Does Normal ALT Exclude Severe Hepatic Fibrosis in Patients with Chronic Hepatitis C? Gastroenterology 2002; Suppl A 631. (Oral presentation in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA) Primary author Does High Body Mass Index Affect Hepatic Fibrosis, Steatosis, and Inflammation in Patients with Chronic Hepatitis C? Gastroenterology 2002; 123, 1 Suppl: Pg. 52 A M1632. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author A Simple Non-invasive Scoring System for Prediction of Severe Hepatic Fibrosis in Chronic HCV Patients Co-infected with HIV. Gastroenterology 2002; 123, 1 Suppl: pg. 50 A M1621. (Presented in the Digestive Disease Week annual meeting, 2002, San Fransisco, California, USA). Primary author Comparison of Detection of Hepatitis C Virus (HCV) by Transcription-Mediated Amplification (TMA) versus COBAS AMPLICOR™ HCV Test, version 2.0 (AMPLICOR) in Patients Undergoing Antiviral Therapy. (Presented in the American Association of Study of Liver Diseases annual meeting, 2002, Boston, Massachusetts, USA). Co-author. Prevalence and risk factors of hepatitis C among pregnant females in Egypt. (Presented at the IASL/AFASLD meeting, 2006, Cairo, Egypt) Liver International Vol 26 (Suppl 1) September 2006. Primary Author.